Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

172/433 Matches for
“AST-to-platelet ratio index”

“AST-to-platelet ratio index” Clear all

  1. Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.

    Usluer G et al. · Eur J Clin Microbiol Infect Dis · 2012 Match 100

    …FIB4, AST/platelet ratio index (APRI), age-platelet (AP) index, Göteborg University…

    FibroTest HCV

  2. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.

    Chou R et al. · Ann Intern Med · 2013 Match 100

    …the platelet count, age-platelet index, aspartate aminotransferase-platelet ratio index (APRI…

    FibroTest HCV

  3. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.

    Castéra L et al. · J Hepatol · 2009 Match 100

    …methods (AST/ALT ratio (AAR), APRI, prothrombin index (PI), platelet count (PC…

    FibroTest HCV

  4. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.

    Köksal İ et al. · Turk J Gastroenterol · 2018 Match 100

    …FibroTest®, aspartate aminotransferase-to-platelet ratio index(APRI), aspartate aminotransferase and alanine…

    FibroTest HCV

  5. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.

    Parikh P et al. · Ann Transl Med · 2017 Match 99

    …Due to the complex natural history of HBV infection, patients require an…

    FibroTest HBV

  6. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.

    Sebastiani G et al. · Aliment Pharmacol Ther · 2012 Match 99

    …of Fibrotest, Forns' index and AST-to-platelet ratio (APRI) have been…

    FibroTest HCV

  7. The non-invasive assessment of hepatic fibrosis.

    Gheorghe G et al. · J Formos Med Assoc · 2021 Match 99

    …The liver biopsy with the histopathological examination is considered to be the…

    ActiTest FibroTest Alcohol HBV +2

  8. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.

    Sebastiani G et al. · J Viral Hepat · 2008 Match 98

    …for AST-to-platelet ratio, Forns' index, AST-to-ALT ratio (AAR…

    FibroTest HCV

  9. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

    Maor Y et al. · Haemophilia · 2006 Match 98

    …FT, AST-to-platelet ratio index (APRI), Forns index, age-platelet index…

    FibroTest HCV

  10. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B.

    Mallet V et al. · Aliment Pharmacol Ther · 2009 Match 98

    …index was more precise than the AST-to-platelet ratio index and…

    FibroTest HBV

  11. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.

    Castera L · J Viral Hepat · 2009 Match 98

    …Transient elastography also appears to be an excellent tool for early detection…

    FibroTest HBV HCV HIV

  12. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.

    Fernandez M et al. · Eur J Gastroenterol Hepatol · 2015 Match 97

    …FS, Fibrotest, FIB-4, aspartate aminotransferase to platelet ratio index (APRI), and…

    FibroTest Alcohol

  13. Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

    Bignulin S et al. · Ann Hepatol · 2016 Match 97

    …This study aimed to assess the accuracy of ARFI in discriminating liver…

    FibroTest HCV

  14. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.

    Adams LA et al. · J Gastroenterol Hepatol · 2011 Match 97

    …Cut-offs were determined by Youden Index or 90% predictive values. ### Results…

    FibroTest Metabolic

  15. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

    Ahmad W et al. · Virol J · 2011 Match 96

    …Different invasive and non invasive methods are applied to diagnose the disease…

    FibroTest HCV

  16. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.

    Lombardi R et al. · World J Gastroenterol · 2015 Match 96

    …to first tier screening of patients at risk, in order to diagnose…

    FibroTest Alcohol

  17. Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?

    Gentile I et al. · Infez Med · 2014 Match 96

    …In managing subjects with HCV chronic infection, it is crucial to perform…

    FibroTest HCV

  18. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

    Sadler MD et al. · Can J Gastroenterol Hepatol · 2015 Match 96

    …M probe; aspartate aminotransferase to platelet ratio index (APRI) and FibroTest (FT…

    FibroTest Other

  19. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.

    Sebastiani G et al. · World J Gastroenterol · 2007 Match 95

    …AST-to-Platelet ratio (APRI), Fornso index, AST-to-ALT Ratio, Goteborg…

    FibroTest HBV

  20. Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children.

    Rubio A et al. · J Pediatr Gastroenterol Nutr · 2009 Match 95

    …SteatoTest, Forns index, aspartate aminotransferase to platelet ratio index, ultrasound, and Fibroscan…

    FibroTest HIV

  21. Non-invasive markers for hepatic fibrosis.

    Baranova A et al. · BMC Gastroenterol · 2011 Match 95

    …Current non-invasive methods range from serum biomarker assays to advanced imaging…

    FibroTest Alcohol HBV HCV +3

  22. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.

    Friedrich-Rust M et al. · J Clin Gastroenterol · 2010 Match 94

    …for FibroTest and AST to platelet ratio index. Histologic steatosis significantly correlated…

    FibroTest SteatoTest Other

  23. Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.

    Matta B et al. · Curr HIV/AIDS Rep · 2016 Match 94

    Patients with HIV have a proclivity to develop liver fibrosis, especially when…

    FibroTest HBV HCV HIV

  24. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.

    Thiele M et al. · Gastroenterology · 2018 Match 94

    …The primary aim was to validate ELF in detection of advanced fibrosis…

    FibroTest Alcohol

  25. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.

    Maor Y et al. · Haemophilia · 2007 Match 94

    …FT, AST-to-platelet ratio index (APRI), Forns index, hyaluronic acid and…

    FibroTest HCV

  26. Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients.

    Salles N et al. · Gastroenterol Clin Biol · 2009 Match 93

    …Hepascore, Aspartate Transaminase (AST) to platelet ratio index [APRI], Forns score, FibroTest…

    FibroTest

  27. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.

    Sebastiani G et al. · Hepatology · 2009 Match 93

    …by combining the AST-to-platelet ratio index and Fibrotest-Fibrosure, thereby…

    FibroTest HCV

  28. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.

    Vilar-Gomez E et al. · J Hepatol · 2018 Match 93

    …4 index are both cost-effective and highly sensitive tools to exclude…

    FibroTest Metabolic

  29. Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastography.

    Knop V et al. · Nutrition · 2019 Match 92

    …The aim of the present study was to evaluate dynamic changes of…

    FibroTest SteatoTest Other

  30. Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

    Perazzo H et al. · Clin Res Hepatol Gastroenterol · 2014 Match 92

    ### Background The aspartate aminotransferase platelet ratio index (APRI) is a validated, non…

    FibroTest Alcohol HBV HCV +1

  31. Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.

    Halfon P et al. · Antivir Ther · 2009 Match 92

    …Fibrotest, the Forn's index, age-platelet ratio index, SHASTA, FIB-4…

    FibroTest HCV HIV

  32. Prognostic value of liver fibrosis biomarkers: a meta-analysis.

    Poynard T et al. · Gastroenterol Hepatol (N Y) · 2011 Match 91

    …as FibroTest, aspartate transaminase-platelet ratio index (APRI), FIB-4, and liver…

    FibroTest Alcohol HBV HCV +3

  33. Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients.

    Crisan D et al. · Hepat Mon · 2012 Match 91

    …aim of this study was to determine the accuracy of certain biomarkers…

    FibroTest HCV

  34. Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

    López Tórrez SM et al. · Front Nutr · 2024 Match 91

    …liver biopsy and aspartate aminotransferase-to-platelet ratio (APRI), fibrosis index-4…

    FibroTest Metabolic

  35. Concordance of non-invasive serology-based scoring indices and transient elastography for liver fibrosis and cirrhosis in chronic hepatitis C.

    Trnačević E et al. · Med Glas (Zenica) · 2021 Match 91

    Aim To assess concordance of eight frequently used serology-based scoring indices…

    FibroTest HCV

  36. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.

    Stasi C et al. · World J Gastroenterol · 2016 Match 90

    …suggested that the AST-to-platelet ratio index or FIB-4 test…

    FibroTest HCV

  37. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.

    Le Calvez S et al. · Hepatology · 2004 Match 90

    FibroTest HCV

  38. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

    Asselah T et al. · Liver Int · 2018 Match 90

    …No patients discontinued treatment due to adverse events. Eight patients reported nine…

    FibroTest HCV

  39. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.

    Stibbe KJ et al. · Scand J Gastroenterol · 2011 Match 89

    …acid (HA), aspartate aminotransferase platelet ratio index (APRI), FibroTest, and Fib-4…

    FibroTest HBV HCV

  40. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.

    Bonnard P et al. · Am J Trop Med Hyg · 2010 Match 89

    …for the aspartate transaminase to platelet ratio index (APRI), Fib-4, Fibrotest…

    FibroTest HBV

  41. Noninvasive evaluation of NAFLD.

    Castera L et al. · Nat Rev Gastroenterol Hepatol · 2013 Match 89

    A common clinical concern in patients with NAFLD is whether they have…

    ActiTest FibroTest NashTest SteatoTest +1

  42. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients.

    Fidai A et al. · Front Cardiovasc Med · 2017 Match 89

    …cell and platelet counts were significantly decreased in comparison to the pediatric…

    FibroTest Other

  43. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.

    Sebastiani G et al. · Aliment Pharmacol Ther · 2011 Match 88

    …APRI, Forns'index, Lok index, AST-to-ALT ratio, Fib-4, platelets…

    FibroTest HBV HCV HIV +1

  44. Progression of liver fibrosis among injection drug users with chronic hepatitis C.

    Wilson LE et al. · Hepatology · 2006 Match 88

    …Predictive values of blood markers [FibroSURE, aspartate aminotransferase-to-platelet-ratio index…

    FibroTest

  45. Biomarkers for liver disease in urea cycle disorders.

    Nagamani SCS et al. · Mol Genet Metab · 2021 Match 88

    ### Background Urea cycle disorders (UCDs) are among the most common inborn errors…

    ActiTest FibroTest Other

  46. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.

    Boursier J et al. · Eur J Gastroenterol Hepatol · 2009 Match 87

    …73.8, 94.9%, aspartate aminotransferase to platelet ratio index (APRI): 71…

    FibroTest HCV

  47. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.

    Castéra L et al. · Aliment Pharmacol Ther · 2011 Match 87

    …TE, Fibrotest and aspartate to platelet ratio index (APRI) the same day…

    FibroTest HBV

  48. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.

    Castéra L et al. · J Hepatol · 2010 Match 87

    …FT) (Castera) or AST-to-Platelet Ratio Index (APRI) and FT (SAFE…

    FibroTest HCV

  49. The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.

    Adler M et al. · Hepatology · 2008 Match 87

    FibroTest Alcohol HBV HCV +1

  50. Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.

    Meritsi A et al. · Clin Diabetes · 2022 Match 86

    …Here, the authors aimed to assess the performance of the most commonly…

    ActiTest FibroTest NashTest-2 Metabolic

  51. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.

    Sène D et al. · Clin Biochem · 2006 Match 86

    …age-platelet, platelet, hyaluronic acid) as non-invasive alternatives to liver biopsy…

    ActiTest FibroTest HCV

  52. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.

    Bottero J et al. · J Hepatol · 2009 Match 86

    …The Kappa index was used to study overall agreement with liver biopsy…

    FibroTest HBV HIV

  53. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.

    Harris R et al. · Lancet Gastroenterol Hepatol · 2017 Match 85

    As of 2016, there is no evidence-based pathway to stratify the…

    FibroTest Other

  54. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

    Sebastiani G et al. · J Hepatol · 2006 Match 85

    …evaluated for AST to platelets ratio (APRI), Forns' index and Fibrotest at…

    FibroTest HCV

  55. Biomarkers of liver fibrosis.

    Poynard T et al. · Adv Clin Chem · 2008 Match 85

    …FT has higher accuracy than aspartate aminotransferase/platelets ratio index (APRI), the…

    ActiTest FibroTest SteatoTest Alcohol +5

  56. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.

    de Lédinghen V et al. · J Pediatr Gastroenterol Nutr · 2007 Match 85

    …to compare FibroScan, Fibrotest, and aspartate transaminase to platelets ratio index (APRI…

    FibroTest HBV HCV Other

  57. Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C.

    Canbakan M et al. · Nephron Clin Pract · 2011 Match 84

    …biopsy and the AST-to-platelet ratio index (APRI) in determining hepatic…

    FibroTest HCV

  58. Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.

    Dai CY et al. · J Hepatol · 2010 Match 84

    …This study aimed to elucidate the association between virologic status and platelet…

    FibroTest HBV HCV

  59. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

    Cacoub P et al. · J Hepatol · 2008 Match 84

    …Fib-4, APRI and the Forn's index were only able to…

    FibroTest HCV HIV

  60. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection.

    Poynard T et al. · Ann Intern Med · 2013 Match 83

    FibroTest HCV

  61. Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study.

    Flores-Calderón J et al. · Ann Hepatol · 2012 Match 83

    ### Introduction Identifying liver fibrosis is important to evaluate the severity of liver…

    FibroTest

  62. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.

    Beckebaum S et al. · Transplantation · 2010 Match 83

    …0.71 (aspartate aminotransferase-to-platelet ratio index), 0.80 and 0…

    FibroTest Alcohol HBV HCV +2

  63. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.

    de Lédinghen V et al. · Aliment Pharmacol Ther · 2013 Match 82

    …In multivariate analysis, FibroTest and liver stiffness had the highest hazard ratio…

    FibroTest HBV

  64. Assessment of liver fibrosis: noninvasive means.

    Poynard T et al. · Saudi J Gastroenterol · 2008 Match 82

    Liver biopsy, owing to its limitations and risks, is an imperfect gold…

    FibroTest Alcohol HBV HCV +3

  65. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.

    Patel K et al. · J Viral Hepat · 2009 Match 82

    …Lower index scores at baseline that continue to decline likely reflect reduced…

    FibroTest HCV

  66. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Key publication

    European Association for Study of Liver et al. · J Hepatol · 2015 Match 82

    FibroTest Alcohol HBV HCV +3

  67. Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.

    Shlomai A et al. · J Viral Hepat · 2013 Match 81

    …acids, age, body mass index, serum AST, glucose and cholesterol levels suggested…

    FibroTest HCV

  68. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography.

    Corradi F et al. · Dig Liver Dis · 2009 Match 81

    …leading to special need of non-invasive validated methods to estimate liver…

    FibroTest HCV

  69. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

    Calès P et al. · J Hepatol · 2010 Match 81

    ### Background & Aims We compared 5 non-specific and 2 specific blood tests…

    FibroTest HCV HIV

  70. Predicting significant fibrosis in hepatitis C patients in Luxembourg using serological markers.

    Mossong J et al. · Bull Soc Sci Med Grand Duche Luxemb · 2011 Match 80

    ### Objective The aim of our study was to assess the diagnostic performance…

    FibroTest HCV

  71. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.

    Calès P et al. · Liver Int · 2008 Match 80

    …0.799, aspartate aminotransferase to platelet ratio index (APRI): 0.786 and…

    FibroTest HCV

  72. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.

    Więcek S et al. · Mediators Inflamm · 2020 Match 80

    …The aim of the study was to evaluate the selected parameters of…

    ActiTest FibroTest Other

  73. Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.

    Park MS et al. · PLoS One · 2013 Match 80

    …Here, we aimed to identify predictors of discordance between FT and liver…

    FibroTest HBV

  74. Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.

    Cheng J et al. · PLoS One · 2015 Match 79

    …The aim of this study was to verify the diagnostic performance and…

    FibroTest HBV

  75. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.

    Bourliere M et al. · Aliment Pharmacol Ther · 2008 Match 79

    …AUCs of aspartate aminotransferase (AST) to Platelets Ratio Index (APRI) and Forns…

    FibroTest HCV

  76. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Key publication

    Shiha G et al. · Hepatol Int · 2009 Match 79

    Liver fibrosis is a common pathway leading to cirrhosis, which is the…

    FibroTest SteatoTest HBV HCV +1

  77. Reproducibility of blood tests of liver fibrosis in clinical practice.

    Calès P et al. · Clin Biochem · 2008 Match 78

    ### Objectives To evaluate the inter-laboratory reproducibility of blood test for liver…

    FibroTest Alcohol HBV HCV +1

  78. Personalized management of cirrhosis by non-invasive tests of liver fibrosis.

    Wong GL et al. · Clin Mol Hepatol · 2015 Match 78

    Owing to the high prevalence of various chronic liver diseases, cirrhosis is…

    FibroTest Alcohol HBV HCV +1

  79. FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients.

    Vallet-Pichard A et al. · Hepatology · 2006 Match 78

    FibroTest HCV

  80. The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy.

    Xu XY et al. · PLoS One · 2014 Match 78

    Noninvasive biomarkers have been developed to predict hepatitis B virus (HBV)-related…

    FibroTest HBV

  81. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.

    Lemoine M et al. · J Acquir Immune Defic Syndr · 2019 Match 77

    …0.96 to 1.00) and 0.88 (0.76 to 0…

    FibroTest NashTest SteatoTest HIV

  82. Combination of fibrosis tests: sequential or synchronous?

    Boursier J et al. · Hepatology · 2009 Match 77

    FibroTest HCV

  83. Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.

    Kim BK et al. · PLoS One · 2012 Match 77

    FibroTest HBV

  84. Liver fibrosis markers in alcoholic liver disease.

    Chrostek L et al. · World J Gastroenterol · 2014 Match 76

    …Staging of liver fibrosis is essential to define prognosis and management of…

    FibroTest Alcohol

  85. Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy.

    Giannini EG et al. · J Gastroenterol Hepatol · 2015 Match 76

    …The study population was subdivided according to baseline FibroSURE test results into…

    FibroTest HCV

  86. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

    Vergniol J et al. · Gastroenterology · 2011 Match 76

    …FibroTest, the aspartate aminotransferase to platelet ratio index, FIB-4), and analyzed…

    FibroTest HCV HIV

  87. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.

    Kim BK et al. · PLoS One · 2012 Match 75

    …We aimed to validate its diagnostic performances in comparison with liver stiffness…

    FibroTest HBV

  88. Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C.

    Maor Y et al. · Haemophilia · 2010 Match 75

    Non-invasive modalities to estimate fibrosis stage are desirable in hepatitis C…

    FibroTest HCV

  89. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers.

    Brühl J et al. · Eur J Gastroenterol Hepatol · 2011 Match 75

    …Established markers of fibrosis, namely, aspartate transaminase-to-platelet ratio index (APRI…

    FibroTest Other

  90. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

    de Lédinghen V et al. · Liver Int · 2012 Match 75

    …The aim of this study was to prospectively evaluate the performance of…

    SteatoTest Metabolic

  91. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia.

    Perazzo H et al. · Aliment Pharmacol Ther · 2014 Match 74

    …mortality and cardiovascular risk. ### Aim To evaluate the prognostic value of non…

    FibroTest SteatoTest Metabolic

  92. Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.

    Rudler M et al. · PLoS One · 2015 Match 74

    ### Background/Aims According to guidelines, the histological diagnosis of severe alcoholic steatohepatitis…

    AshTest Alcohol

  93. Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis.

    Fierbinteanu-Braticevici C et al. · World J Gastroenterol · 2009 Match 74

    …and was superior to other noninvasive methods (APRI Index, FibroMax) for staging…

    FibroTest HCV

  94. Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.

    Chen SH et al. · BMC Gastroenterol · 2012 Match 73

    …METAVIR F stages, body mass index, and platelet count were also independently…

    FibroTest HCV

  95. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

    Match 73

    FibroTest HBV

  96. Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection.

    Shaheen AA et al. · HIV Clin Trials · 2008 Match 73

    …Our objective was to systematically review studies describing the accuracy of serum…

    FibroTest HCV HIV

  97. Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.

    Myers RP et al. · Dig Dis Sci · 2003 Match 73

    As an alternative to liver biopsy, an index of five biochemical markers…

    FibroTest HCV

  98. Hepatitis B: are non-invasive markers of liver fibrosis reliable?

    Castera L · Liver Int · 2014 Match 72

    Liver biopsy, which was traditionally considered to be the gold standard for…

    FibroTest HBV HCV

  99. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication

    Myers RP et al. · Can J Gastroenterol · 2012 Match 72

    …In addition, recommendations are made regarding approaches to reducing the burden of…

    FibroTest HCV

  100. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.

    Bonnard P et al. · J Viral Hepat · 2015 Match 72

    In Egypt, as elsewhere, liver biopsy (LB) remains the gold standard to…

    FibroTest HCV

  101. Noninvasive diagnosis in alcohol-related liver disease. Review

    Hadefi A et al. · Health Sci Rep · 2020 Match 71

    …Among the noninvasive surrogate markers and techniques used to detect liver fibrosis…

    FibroTest Alcohol

  102. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

    Castéra L et al. · Gastroenterology · 2005 Match 71

    …and the aspartate transaminase to platelets ratio index [APRI]); a liver biopsy…

    FibroTest HCV

  103. Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B.

    Houot M et al. · Aliment Pharmacol Ther · 2016 Match 71

    …of FibroTest, aspartate aminotransferase-platelet ratio index (APRI), FIB4 or TE, with…

    FibroTest HBV HCV

  104. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.

    Sagrini E et al. · Eur J Gastroenterol Hepatol · 2013 Match 71

    …The aim of this study was to develop a nomogram, on the…

    FibroTest HCV

  105. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.

    Bosselut N et al. · Clin Chim Acta · 2013 Match 70

    …In this study, we aimed to design a new score in chronic…

    FibroTest HCV

  106. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Review

    Moreno C et al. · J Hepatol · 2019 Match 70

    …During the last decade, non-invasive tests have been developed to estimate…

    FibroTest Alcohol

  107. Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.

    de Lédinghen V et al. · Dig Liver Dis · 2012 Match 70

    …nonalcoholic fatty liver disease leading to cirrhosis. Existing guidelines do not advocate…

    FibroTest Metabolic

  108. Guidelines for the screening, care and treatment of persons with hepatitis C infection Key publication

    Match 69

    FibroTest HCV

  109. FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B.

    Zeremski M et al. · BMC Gastroenterol · 2014 Match 69

    …with AST levels has an excellent capacity to identify moderate to high…

    ActiTest FibroTest HBV

  110. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication

    Poynard T et al. · Gastroenterol Clin Biol · 2008 Match 69

    …A scoring system has been updated to better compare the quality of…

    ActiTest FibroTest SteatoTest Alcohol +5

  111. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.

    Sturm N et al. · Liver Int · 2013 Match 69

    …Hepatic stellate cell activation index was also higher in CHC than in…

    FibroTest HBV HCV

  112. Changes of non-invasive markers and FibroScan values during HCV treatment.

    Vergniol J et al. · J Viral Hepat · 2009 Match 68

    …The aim of this prospective study was to evaluate changes in liver…

    FibroTest HCV

  113. Current Possibilities to Assess the Degree of Liver Fibrosis in Patients with Haemophilia Infected with HCV--Review.

    Kucharska M et al. · Adv Clin Exp Med · 2015 Match 68

    …Until recently, in order to assess its severity, it was necessary to…

    FibroTest HCV

  114. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

    Leroy V et al. · J Hepatol · 2007 Match 68

    …The aim of this study was to compare the diagnostic performance of…

    FibroTest HCV

  115. Evaluation of liver stiffness measurement by fibroscan as compared to liver biopsy for assessment of hepatic fibrosis in children with chronic hepatitis C.

    Awad Mel-D et al. · J Egypt Soc Parasitol · 2013 Match 67

    …Fibrotest, Actitest, AST-to-platelet ratio index, Forns index and hyaluronic acid…

    ActiTest FibroTest HCV

  116. Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis.

    Haseltine EL et al. · J Viral Hepat · 2015 Match 67

    …We sought to quantify whether liver health improves following successful treatment with…

    FibroTest HCV

  117. Non-invasive diagnosis and follow-up of portal hypertension.

    Thabut D et al. · Clin Res Hepatol Gastroenterol · 2022 Match 67

    …20 kPa or platelet count ≤50 G/l). Platelet count and liver…

    FibroTest Alcohol HBV HCV +1

  118. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.

    Bourliere M et al. · J Viral Hepat · 2006 Match 66

    …FibroTest (FT), aspartate aminotransferase to platelet ratio index (APRI) and Forns score…

    FibroTest HCV

  119. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.

    Vermehren J et al. · BMC Gastroenterol · 2012 Match 66

    …The impact of other risk factors, including prolonged exposure to combined antiretroviral…

    FibroTest HCV HIV

  120. A novel panel of blood markers to assess the degree of liver fibrosis.

    Calès P et al. · Hepatology · 2005 Match 66

    The objective was to develop new blood tests to characterize different fibrosis…

    FibroTest Alcohol HBV HCV

  121. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

    Boursier J et al. · Hepatology · 2012 Match 66

    …with the aspartate aminotransferase-to-platelet ratio index (APRI) or FibroScan, are…

    FibroTest HCV

  122. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

    Halfon P et al. · Am J Gastroenterol · 2006 Match 65

    …The aim of this study was to perform an external validation of…

    ActiTest FibroTest HCV

  123. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Key publication

    Naveau S et al. · Hepatology · 2009 Match 65

    …The aim of the study was to compare the diagnostic and prognostic…

    ActiTest AshTest FibroTest Alcohol

  124. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.

    Schmid P et al. · PLoS One · 2015 Match 65

    ### Objectives To evaluate the diagnostic performance of seven non-invasive tests (NITs…

    FibroTest HCV HIV

  125. Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.

    Denimal D et al. · Cardiovasc Diabetol · 2024 Match 64

    …The primary objective of the present study was to investigate whether the…

    ActiTest FibroTest NashTest SteatoTest +1

  126. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. Key publication

    Ratziu V et al. · BMC Gastroenterol · 2006 Match 64

    …The aim of this study was to determine the diagnostic utility of…

    FibroTest Metabolic

  127. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.

    Boyd A et al. · J Int AIDS Soc · 2017 Match 64

    …The aim of this study was to evaluate the evolution of liver…

    FibroTest HBV HIV

  128. Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

    Peta V et al. · World J Hepatol · 2025 Match 64

    …because of insufficient data. ### Aim To investigate the diagnostic performance of three…

    ActiTest FibroTest AIH

  129. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Key publication

    Imbert-Bismut F et al. · Lancet · 2001 Match 63

    …We aimed, in our prospective study, to assess the predictive value of…

    FibroTest HCV

  130. Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

    Ofei SY et al. · Int J Cardiol · 2015 Match 63

    FibroTest Other

  131. The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis test.

    Munteanu M et al. · Am J Gastroenterol · 2011 Match 63

    FibroTest HCV

  132. Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

    Denimal D et al. · Cardiovasc Diabetol · 2025 Match 62

    …This study aimed to investigate whether the biomarkers of MASLD included in…

    ActiTest FibroTest NashTest SteatoTest +1

  133. FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

    Morra R et al. · Hepatology · 2008 Match 62

    FibroTest Alcohol HBV HCV

  134. Altered serum N-glycomics in chronic hepatitis B patients.

    Gui HL et al. · Liver Int · 2010 Match 62

    …Our present study aimed to evaluate the use of serum glycan markers…

    FibroTest HBV

  135. [Biomarkers for liver fibrosis: advances, advantages and disadvantages].

    Cequera A et al. · Rev Gastroenterol Mex · 2014 Match 62

    Liver cirrhosis in Mexico is one of the most important causes of…

    FibroTest HCV

  136. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.

    Grigorescu M et al. · J Gastrointestin Liver Dis · 2007 Match 61

    ### Aim To assess the diagnostic value of FibroTest to discriminate between insignificant…

    FibroTest HCV

  137. Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

    Lee S et al. · World J Gastroenterol · 2014 Match 61

    …Twenty-three percent of patients with CHB progress naturally to liver cirrhosis…

    FibroTest HBV

  138. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis. Review

    Surial B et al. · Liver Int · 2021 Match 61

    …and cancer surveillance, we aimed to estimate the prevalence of cirrhosis among…

    FibroTest HBV

  139. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action. Review

    Bril F et al. · Diabetes Care · 2017 Match 60

    …Although the increasing prevalence of NAFLD is frequently attributed to the epidemic…

    FibroTest Metabolic

  140. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.

    Grattagliano I et al. · Ann Hepatol · 2013 Match 60

    The diagnostic utilities of ultrasonography (US), fatty liver index (FLI) and an…

    ActiTest FibroTest NashTest SteatoTest +1

  141. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

    Poynard T et al. · Hepatology · 2003 Match 60

    …The aim was to validate their usefulness as surrogate markers of histologic…

    ActiTest FibroTest HCV

  142. Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.

    Crisan D et al. · Indian J Med Res · 2017 Match 60

    ### Background & Objectives One of the multiple factors contributing to virological response in…

    ActiTest FibroTest SteatoTest HCV

  143. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Key publication

    Nguyen-Khac E et al. · Aliment Pharmacol Ther · 2008 Match 59

    …Aims To assess Fibroscan for non-invasive diagnosis of asymptomatic liver fibrosis…

    FibroTest Alcohol

  144. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

    Festi D et al. · Aliment Pharmacol Ther · 2013 Match 59

    …The articles cited were selected based on their relevancy to the objective…

    SteatoTest

  145. Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease.

    Voican CS et al. · Liver Int · 2017 Match 59

    ### Background & Aims The reliability of transient elastography (TE) to assess liver fibrosis…

    FibroTest Alcohol

  146. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.

    Afdhal NH et al. · J Viral Hepat · 2013 Match 58

    …In replacing interferon-based therapies, all-oral regimens are expected to be…

    ActiTest FibroTest HCV

  147. Systematic review: Investigating the prognostic performance of four non-invasive tests in alcohol-related liver disease.

    Rhodes FA et al. · J Gastroenterol Hepatol · 2021 Match 58

    …Non-invasive tests (NITs) are increasingly used to detect fibrosis, but their…

    FibroTest Alcohol

  148. FibroMAX: towards a new universal biomarker of liver disease?

    Morra R et al. · Expert Rev Mol Diagn · 2007 Match 58

    …and a better benefit-to-risk ratio than biopsy of five combinations…

    ActiTest AshTest FibroTest NashTest +7

  149. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.

    Zarski JP et al. · J Hepatol · 2012 Match 57

    …Hepascore®) to 0.83 (FIB-4) for cirrhosis. ### Conclusions Contrarily to blood…

    FibroTest HCV

  150. Implementing non-invasive markers for liver fibrosis in clinical practice.

    Sebastiani G et al. · J Hepatol · 2008 Match 57

    FibroTest HCV

  151. Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.

    Friedrich-Rust M et al. · Ultraschall Med · 2009 Match 57

    …The aim of the present study was to validate real-time elastography…

    FibroTest Alcohol HBV HCV +2

  152. The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.

    Younossi ZM et al. · Gastroenterology · 2021 Match 57

    …Of those with baseline F3 disease, 16.7% experienced disease progression to…

    FibroTest Metabolic

  153. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.

    Naveau S et al. · Clin Gastroenterol Hepatol · 2005 Match 56

    ### Background & Aims The aim of this study was to determine the diagnostic…

    FibroTest Alcohol

  154. Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis.

    Vermehren J et al. · Liver Int · 2012 Match 56

    …liver fibrosis and cirrhosis. ### Aim To determine the diagnostic accuracy of ARFI…

    FibroTest Alcohol HBV HCV +3

  155. EASL clinical practical guidelines: management of alcoholic liver disease.

    European Association for the Study of Liver · J Hepatol · 2012 Match 56

    FibroTest Alcohol

  156. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.

    Laharie D et al. · Eur J Gastroenterol Hepatol · 2010 Match 55

    ### Background The only way to diagnose nodular regenerative hyperplasia (NRH) is liver…

    FibroTest Other

  157. Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.

    Poynard T et al. · Aliment Pharmacol Ther · 2021 Match 55

    …steatohepatitis (NASH) and steatosis. ### Aims To validate externally the performances of a…

    FibroTest NashTest-2 SteatoTest Metabolic

  158. Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.

    Laharie D et al. · J Hepatol · 2010 Match 55

    …The aim of this case-control study was to determine factors associated…

    FibroTest Other

  159. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

    Poynard T et al. · Clin Chem · 2004 Match 55

    …The aims of this study were to assess the quality of biopsy…

    ActiTest FibroTest HCV

  160. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.

    Munteanu M et al. · Aliment Pharmacol Ther · 2016 Match 54

    …We used nonbinary-ROC (NonBinAUROC) as the main endpoint to prevent spectrum…

    ActiTest FibroTest SteatoTest Metabolic

  161. Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis.

    Friedrich-Rust M et al. · J Cyst Fibros · 2013 Match 54

    …The aim of the present study was to evaluate the prevalence of…

    FibroTest Other

  162. Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).

    Munteanu M et al. · Comp Hepatol · 2004 Match 54

    …Considering this premise, the primary aim of this study was to assess…

    ActiTest FibroTest Alcohol HBV +3

  163. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.

    Castera L et al. · HIV Med · 2014 Match 53

    …FT), the aspartate aminotransferase-to-platelet ratio index (APRI) and two algorithms…

    FibroTest HCV HIV

  164. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus. Key publication

    Poynard T et al. · J Viral Hepat · 2009 Match 53

    The aim was to assess the utility of FibroTest-ActiTest (FT-AT…

    ActiTest FibroTest HBV

  165. Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Preda CM et al. · Liver Int · 2018 Match 53

    …liver decompensation (1.9%), related to hepatic dysfunction, and lower platelet count.

    FibroTest HCV

  166. EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

    European Association for the Study of the Liver · J Hepatol · 2011 Match 53

    ActiTest FibroTest HCV

  167. The Diagnostic Value of FibroTest and Hepascore as Non-Invasive Markers of Liver Fibrosis in Primary Sclerosing Cholangitis (PSC).

    Cylwik B et al. · J Clin Med · 2023 Match 52

    The aim of this study was to evaluate the diagnostic usefulness of…

    FibroTest Other

  168. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

    Terrault NA et al. · Hepatology · 2018 Match 52

    ActiTest FibroTest HBV

  169. Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

    Poynard T et al. · Curr Hepat Rep · 2011 Match 52

    A serum biomarker (FibroTest; Biopredictive, Paris, France; FibroSure; LabCorp, Burlington, USA) and…

    FibroTest HBV

  170. Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.

    Zarski JP et al. · Liver Int · 2010 Match 51

    …Blood tests could be useful to assess liver fibrosis changes in clinical…

    ActiTest FibroTest HCV

  171. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Key publication

    Halfon P et al. · Gastroenterol Clin Biol · 2008 Match 51

    …The primary aim of the present study was to update a previous…

    FibroTest Alcohol HBV HCV +2

  172. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.

    Leroy V et al. · J Hepatol · 2014 Match 51

    …The aim of this study was to describe the diagnostic performance of…

    FibroTest HBV HCV

Showing the full result list. The page is server-rendered and not paginated.